FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/063576 [Registered on: 04/03/2024] Trial Registered Prospectively
Last Modified On: 04/03/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To see the efficacy of oral minoxidil versus topical minoxidil in male pattern hair loss. 
Scientific Title of Study   Comparison Of efficacy Of oral minoxidil 1.25mg vs topical minoxidil 5% in male androgenetic alopecia -a randomised open label pilot study. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Bikash Ranjan Kar 
Designation  HOD and Professor 
Affiliation  IMS and Sum hospital 
Address  Department of skin and venerology, ims and sum hospital,kalinganagar

Khordha
ORISSA
751003
India 
Phone  9937428181  
Fax    
Email  karbikash@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Bikash Ranjan Kar 
Designation  HOD and Professor 
Affiliation  IMS and Sum hospital 
Address  Department of skin and venerology, ims and sum hospital,kalinganagar

Khordha
ORISSA
751003
India 
Phone  9937428181  
Fax    
Email  karbikash@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Bikash Ranjan Kar 
Designation  HOD and Professor 
Affiliation  IMS and Sum hospital 
Address  Department of skin and venerology, ims and sum hospital,kalinganagar

Khordha
ORISSA
751003
India 
Phone  9937428181  
Fax    
Email  karbikash@gmail.com  
 
Source of Monetary or Material Support  
IMS and SUM Hospital Department of DVL K 8, Kalinga Nagar Bhubaneswar 
 
Primary Sponsor  
Name  not applicable 
Address  not applicable 
Type of Sponsor  Other [no] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bikash Ranjan  institute of medical science and sum hospital  Department of DVL K 8, Kalinga Nagar Bhubaneswar
Khordha
ORISSA 
9937428181

karbikash@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee ims and sum hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L649||Androgenic alopecia, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  oral minoxidil 1.25mg   tablet minoxidil 1.25mg once daily for 24 weeks follow up every 4-weekly for 24weeks 
Comparator Agent  topical minoxidil 5% solution  Topical minoxidil lotion 1ml once daily for 24 weeks follow up 4-weekly for 24 weeks 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Male 
Details  1.All males aged 18-45 yrs of age
2. Males with ( Hamilton Norwood Scale II-IV) 
 
ExclusionCriteria 
Details  1.Severe hypertension, moderate hypertension on
antihypertensive therapy
2.Cardiovascular dysfunction
3.History of minoxidil hypersensitivity
4.On treatment with formulation of minoxidil, DHT-
blockers or other treatments for AGA in the past 3 months.
5.Psychiatric or scalp disease 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Clinical photographic assessment and quantitative
assessment using densitometer will be done.
2.Hair density calculation will be done in a square inch
area 
every monthly for 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
The number of vellus hairs, terminal hairs determined by their thickness in the specific square inch area  every monthly for 6 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   14/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Low dose oral Minoxidil 0.25-5mg/day has been used off label to treat various forms of Alopecia.Oral Minoxidil has ; many patients find oral administration more convenient than topical application of a lotion or foam,
topical application is operator dependent i.e some parts of the scalp may be missed in those with widespread alopecia, and low dose oral minoxidil circumvents the local side effects associated with topical minoxidil such as irritation and allergic contact dermatitis.
One group shall be treated with oral minoxidil
1.25mg for 24 weeks
2. Second group shall be treated with topical
minoxidil 5% for 24 weeks.
Outcome-
1.Clinical photographic assessment and quantitative
assessment using densitometer will be done.
2.Hair density calculation will be done in a square inch
area from a point formed by intersection of lines joining
glabella and occiput and joining the parietal prominences.
3.The number of vellus hairs, terminal hairs will be
counted in the specific square inch area.
 
Close